'Global western blotting market' presentation slideshows

Western Blotting Market Worth 730.7 Million USD by 2021

The western blotting market is expected to reach USD 730.7 Million in 2021 from USD 574.8 Million in 2016, growing at a CAGR of 4.9%. Increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years. The global market is segmented on the basis of product, application, and end user. By product, the market is categorized into consumables and instruments. The consumables segment is estimated to account for the largest share of the global market, by product in 2016. The western blotting instruments segment is segmented into gel electrophoresis instruments, blotting systems, and imagers. The blotting systems segment is expected to account for the largest share of the instruments market, by type in 2016 and is expected to grow at the highest CAGR during the forecast period (2016-2021). The western blotting consumables segment is further segmented into reagents, kits, and others (transfer membranes, blotting papers, primary & secondary antibodies, and gels, among others). Based on the applications, the global western blotting market is segmented into biomedical & biochemical research, disease diagnostics, agriculture, and others (quality control and biologics). The biomedical & biochemical research segment is expected to account for the largest share of the global market, by application in 2016. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021, owing to increasing diagnosis, incidences, and prevalence of HIV, HSV, HBV, Lyme disease, and mad cow’s disease among others. The western blotting market, by end user is segmented into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others (CROs, food & beverage companies, and forensic laboratories). The academic & research institutes segment is expected to command the largest share of the global market, by end user in 2016. However, the diagnostic centers segment is projected to grow at the highest CAGR from 2016 to 2021.

141 views • 11 slides

Medical aesthetics market worth 13.29 billion usd by 2021

This report studies the global medical aesthetics market over the forecast period of 2016 to 2021. The market is expected to reach USD 13.29 Billion by 2021, at CAGR of 10.8% from 2016 to 2021. A number of factors such as increasing inclination towards minimally invasive and non-invasive aesthetic procedures, rising demand for aesthetic treatments among the male population, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. On the other hand, stringent safety regulations for aesthetic procedures and low focus of market players on development of medical aesthetic devices for dermatological conditions are restricting the growth of the global medical aesthetics market. The report covers nine major product types- energy-based devices, breast implants, facial aesthetics, tattoo removal devices, physician-dispensed cosmeceuticals and skin lighteners, thread lifting, physician-dispensed eyelash products, laser resurfacing devices, and laser hair removal devices. The energy-based devices segment is categorized into skin tightening and body shaping, liposuction devices, cellulite reduction devices and non-invasive fat reduction devices. The breast implants segment is classified into silicone breast implants, saline breast implants, and cohesive semi-solid gel implants. The facial aesthetics segment is also categorized botulinum toxin (BOTOX), chemical peels, microdermabrasion, and dermal fillers. Physician dispensed cosmeceuticals segment is expected to grow at the highest CAGR, mainly due to increasing aging population coupled with rising demand for anti-aging products to treat wrinkles and visible signs of aging, Based on end-users, the global medical aesthetics market is categorized into two major segments, namely, clinics plus medical spas and beauty centers. The clinics and medical spas segment is expected to account for the larger share of the global medical aesthetic market in 2016 and grow at the higher CAGR during the forecast period. This can be attributed to the growing number of clinics and medical spas and increasing number of skilled professionals to perform the aesthetic procedures. In 2016, North America is expected to hold the largest share of the global medical aesthetic market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, such as growing number of aesthetic procedures, rising middle class with growing purchasing power , rising medical tourism, and increasing focus of global players is driving the growth of Asia-Pacific market. Allergan, Inc. (Ireland), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Mentor Worldwide LLC (U.S PhotoMedex, Inc. (U.S.), Solta Medical, Inc. (U.S), Syneron Medical, Ltd. (Israel), Galderma S.A. (Switzerland), and ZELTIQ Aesthetics, Inc. (U.S.) are some of the main players in the global medical aesthetics market.

135 views • 11 slides

Technology advancement in medical aesthetics market

This report studies the global medical aesthetics market over the forecast period of 2016 to 2021. The market is expected to reach USD 13.29 Billion by 2021, at CAGR of 10.8% from 2016 to 2021. A number of factors such as increasing inclination towards minimally invasive and non-invasive aesthetic procedures, rising demand for aesthetic treatments among the male population, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. On the other hand, stringent safety regulations for aesthetic procedures and low focus of market players on development of medical aesthetic devices for dermatological conditions are restricting the growth of the global medical aesthetics market. The report covers nine major product types- energy-based devices, breast implants, facial aesthetics, tattoo removal devices, physician-dispensed cosmeceuticals and skin lighteners, thread lifting, physician-dispensed eyelash products, laser resurfacing devices, and laser hair removal devices. The energy-based devices segment is categorized into skin tightening and body shaping, liposuction devices, cellulite reduction devices and non-invasive fat reduction devices. The breast implants segment is classified into silicone breast implants, saline breast implants, and cohesive semi-solid gel implants. The facial aesthetics segment is also categorized botulinum toxin (BOTOX), chemical peels, microdermabrasion, and dermal fillers. Physician dispensed cosmeceuticals segment is expected to grow at the highest CAGR, mainly due to increasing aging population coupled with rising demand for anti-aging products to treat wrinkles and visible signs of aging, Based on end-users, the global medical aesthetics market is categorized into two major segments, namely, clinics plus medical spas and beauty centers. The clinics and medical spas segment is expected to account for the larger share of the global medical aesthetic market in 2016 and grow at the higher CAGR during the forecast period. This can be attributed to the growing number of clinics and medical spas and increasing number of skilled professionals to perform the aesthetic procedures. In 2016, North America is expected to hold the largest share of the global medical aesthetic market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, such as growing number of aesthetic procedures, rising middle class with growing purchasing power , rising medical tourism, and increasing focus of global players is driving the growth of Asia-Pacific market. Allergan, Inc. (Ireland), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Mentor Worldwide LLC (U.S PhotoMedex, Inc. (U.S.), Solta Medical, Inc. (U.S), Syneron Medical, Ltd. (Israel), Galderma S.A. (Switzerland), and ZELTIQ Aesthetics, Inc. (U.S.) are some of the main players in the global medical aesthetics market.

161 views • 11 slides

Detailed Qualitative & Quantitative Analysis Medical Aesthetics Market

Medical aesthetics devices are used to improve the cosmetic appearance through the treatment of conditions such as liver spots, excess fat, scars, skin laxity, wrinkles, moles, cellulite, unwanted hair, spider veins, and skin discoloration. The global Medical aesthetics market is estimated to grow at a CAGR of 10.8% from 2016 to 2021 to reach USD 13.29 Billion by 2021. Key factors such as the growing adoption of non-invasive procedures, growth in aging population, increasing awareness among customers, technological advancements in energy-based medical aesthetics devices, and increasing demand for aesthetic treatments among the male population are driving the growth of the aesthetic devices market. However, stringent safety regulations for aesthetic procedures, social stigma associated with cosmetic treatments, and low focus of market players on developing medical aesthetic devices for dermatological conditions are restraining the growth of this market. Based on product, the medical aesthetics market is categorized into energy-based devices, breast implants, facial aesthetics, tattoo removal, physician-dispensed cosmeceuticals and skin lighteners, physician-dispensed eyelash products, thread lifting, laser resurfacing devices, and laser hair removal. The facial aesthetics segment is expected to account for the largest share of the medical aesthetics market in 2016. The large share of this segment can be attributed to the growing patient demand for facial aesthetic treatments, increasing demand of non-invasive cosmetic procedures, launch of new products, and growth in aging population. On the basis of end user, the market is segmented into clinics plus medical spas and beauty centres. The clinics and medical spas segment is estimated to register the higher CAGR from 2016 to 2021. The high growth of this segment is primarily attributed to the growing number of clinics and medical spas and increasing number of skilled professionals to perform the aesthetic procedures, rapidly increasing aging and obese population across the globe, increasing preference for minimally invasive and non-invasive aesthetic procedures. In 2016, North America is expected to account for the largest share of the global medical aesthetics market, followed by Europe. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, owning to key factors such as rising consumer awareness and interest in aesthetic procedures, aggressive marketing by leading U.S. and European companies, and rising medical tourism in the region. Over the past three years, a number of market players, including Cynosure, Inc. (U.S.), Syneron Medical Ltd. (Israel), Allergan, Inc. (U.S.), and Galderma S.A. (Switzerland) have strategically expanded their presence in emerging Asia-Pacific countries to leverage the high growth potential in the region.

131 views • 11 slides

$730.7 Billion Western Blotting Market to 2021 - Global Analysis and Forecasts by Products, Technology & Application

The western blotting market is expected to reach USD 730.7 Million in 2021 from USD 574.8 Million in 2016, growing at a CAGR of 4.9%. Increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years. The global market is segmented on the basis of product, application, and end user. By product, the market is categorized into consumables and instruments. The consumables segment is estimated to account for the largest share of the global market, by product in 2016. The western blotting instruments segment is segmented into gel electrophoresis instruments, blotting systems, and imagers. The blotting systems segment is expected to account for the largest share of the instruments market, by type in 2016 and is expected to grow at the highest CAGR during the forecast period (2016-2021). The western blotting consumables segment is further segmented into reagents, kits, and others (transfer membranes, blotting papers, primary & secondary antibodies, and gels, among others). Based on the applications, the global western blotting market is segmented into biomedical & biochemical research, disease diagnostics, agriculture, and others (quality control and biologics). The biomedical & biochemical research segment is expected to account for the largest share of the global market, by application in 2016. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021, owing to increasing diagnosis, incidences, and prevalence of HIV, HSV, HBV, Lyme disease, and mad cow’s disease among others. The western blotting market, by end user is segmented into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others (CROs, food & beverage companies, and forensic laboratories). The academic & research institutes segment is expected to command the largest share of the global market, by end user in 2016. However, the diagnostic centers segment is projected to grow at the highest CAGR from 2016 to 2021.

136 views • 11 slides

Western Blotting Market worth $730.7 Million by 2021

114 views • 9 slides

Analysis: Western Blotting Market The Western Blotting Market accounted to USD 728.3 million in 2016 growing at a CAGR of 5.10% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

57 views • 5 slides